GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Scope Fluidics Spolka Akcyjna (WAR:SCP) » Definitions » Net Margin %

Scope Fluidics Spolka Akcyjna (WAR:SCP) Net Margin % : -27,225.00% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Scope Fluidics Spolka Akcyjna Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Scope Fluidics Spolka Akcyjna's Net Income for the three months ended in Sep. 2024 was zł-6.53 Mil. Scope Fluidics Spolka Akcyjna's Revenue for the three months ended in Sep. 2024 was zł0.02 Mil. Therefore, Scope Fluidics Spolka Akcyjna's net margin for the quarter that ended in Sep. 2024 was -27,225.00%.

The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Net Margin % or its related term are showing as below:

WAR:SCP' s Net Margin % Range Over the Past 10 Years
Min: -208650   Med: -2782   Max: 78833.91
Current: -23468.91


WAR:SCP's Net Margin % is ranked worse than
99.07% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: -7.645 vs WAR:SCP: -23468.91

Scope Fluidics Spolka Akcyjna Net Margin % Historical Data

The historical data trend for Scope Fluidics Spolka Akcyjna's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scope Fluidics Spolka Akcyjna Net Margin % Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial - - - 78,833.91 -3,640.50

Scope Fluidics Spolka Akcyjna Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -176,300.00 -99,487.50 -18,494.59 -13,184.00 -27,225.00

Competitive Comparison of Scope Fluidics Spolka Akcyjna's Net Margin %

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Net Margin % distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Net Margin % falls into.


;
;

Scope Fluidics Spolka Akcyjna Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Scope Fluidics Spolka Akcyjna's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-18.785/0.516
=-3,640.50 %

Scope Fluidics Spolka Akcyjna's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-6.534/0.024
=-27,225.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scope Fluidics Spolka Akcyjna  (WAR:SCP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Scope Fluidics Spolka Akcyjna Net Margin % Related Terms

Thank you for viewing the detailed overview of Scope Fluidics Spolka Akcyjna's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Scope Fluidics Spolka Akcyjna Business Description

Traded in Other Exchanges
Address
Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.

Scope Fluidics Spolka Akcyjna Headlines

No Headlines